252 related articles for article (PubMed ID: 31069596)
21. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
22. Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer.
Tong W; Sun D; Wang Q; Suo J
Cell Biochem Biophys; 2015 Jun; 72(2):453-9. PubMed ID: 25567655
[TBL] [Abstract][Full Text] [Related]
23. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
24. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
25. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
26. MOR promotes epithelial-mesenchymal transition and proliferation via PI3K/AKT signaling pathway in human colorectal cancer.
Gao L; Yang L; He Y; Liu Y; Xu P; Zhang J; Dai S; Luo X; Sun Z
Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 55(1):72-80. PubMed ID: 35983971
[TBL] [Abstract][Full Text] [Related]
27. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
Tao Y; Han T; Zhang T; Sun C
Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
[TBL] [Abstract][Full Text] [Related]
28. MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
Zhao Q; Xu L; Sun X; Zhang K; Shen H; Tian Y; Sun F; Li Y
Tumour Biol; 2017 Jun; 39(6):1010428317707881. PubMed ID: 28653875
[TBL] [Abstract][Full Text] [Related]
29. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
Hu J; Li G; Liu L; Wang Y; Li X; Gong J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
[TBL] [Abstract][Full Text] [Related]
30. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
[TBL] [Abstract][Full Text] [Related]
31. Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.
Yang Y; Zhang M; Jin C; Ding Y; Yang M; Wang R; Zhou Y; Zhou Y; Li T; Wang K; Hu R
J Cell Biochem; 2019 Oct; 120(10):17744-17756. PubMed ID: 31210372
[TBL] [Abstract][Full Text] [Related]
32. Perfluorooctane sulfonate promotes the migration of colorectal cancer cells by inducing epithelial-mesenchymal transition.
Li F; Chen L; Peng BX; Lei Y; Li M; Guo LH
J Environ Sci (China); 2024 Nov; 145():1-12. PubMed ID: 38844310
[TBL] [Abstract][Full Text] [Related]
33. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
[TBL] [Abstract][Full Text] [Related]
34. Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in
Miller SA; Policastro RA; Savant SS; Sriramkumar S; Ding N; Lu X; Mohammad HP; Cao S; Kalin JH; Cole PA; Zentner GE; O'Hagan HM
Mol Cancer Res; 2020 Feb; 18(2):264-277. PubMed ID: 31704733
[TBL] [Abstract][Full Text] [Related]
35. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
36. SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway.
Gu X; Jiang Y; Xue W; Song C; Wang Y; Liu Y; Cui B
Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):861-871. PubMed ID: 31206801
[TBL] [Abstract][Full Text] [Related]
37. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
Qin A; Qian W
Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
[TBL] [Abstract][Full Text] [Related]
39. SPAG5 promotes the proliferation, migration, invasion, and epithelial-mesenchymal transformation of colorectal cancer cells by activating the PI3K/AKT signaling pathway.
Zhang X; Wu W; Li X; He F; Zhang L
Chin J Physiol; 2023; 66(5):365-371. PubMed ID: 37929348
[TBL] [Abstract][Full Text] [Related]
40. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]